YOUR WEIGHT-LOSS DRUG MIGHT ALSO BE SAVING YOUR LIFE : OZEMPIC LINKED TO A DRAMATIC 30% DROP IN BREAST CANCER RISK
A drug that transformed diabetes care and sparked a weight-loss revolution may now be reshaping cancer prevention. New research presented at ASCO 2026 suggests women taking GLP-1 medications such as Ozempic and Wegovy were significantly less likely to develop breast cancer, in what could become one of the most important medical discoveries of the decade…